XML 127 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Cash flows used in operating activities        
Net loss $ (7,118,223) $ (4,723,407) $ (13,763,658) $ (12,073,260)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 40,828 42,240 84,479 90,923
Accretion of discount on promissory note     24,273
Accrued expenditures for government grant (66,423) (80,000)
Accrued interest     8,230
Accrued interest income, related party 2,550 (2,550)
Change in fair value of warrant liability 432,933 16,658 4,085,284 (1,823,444)
Change in fair value of bonus rights liability (37,360) 2,123 75,830 8,295
Provision for loan losses 55,000    
Impairment of intangible assets 39,166    
Share-based compensation 723,412 1,202,356 2,369,585 1,777,271
Loss on write-off of equipment     5,506
Shares issued for services 2,273,949    
Changes in non-cash operating working capital items:        
Prepaid expenses and other current assets (67,766) 127,109 (117,271) 619,787
Accounts payable and accrued liabilities (151,880) (1,832,532) (1,451,264) 2,110,301
Net cash used in operating activities (3,873,814) (5,165,453) (8,799,565) (9,252,118)
Cash flows provided by (used in) investing activities        
Acquisition of equipment     (4,876)
Net cash provided by (used in) investing activities (4,876)
Cash flows provided by financing activities        
Units issued for cash 3,732,469 4,506,055 9,223,587
Exercise of options 1,800 10,500 27,000 40,785
Proceeds received less expenses from government grant     201,500
Exercise of warrants 160,000    
Proceeds received from restricted government grant 290,825    
Amounts paid from restricted government grant funds (205,917) (111,087)
Share issuance costs (405,753) (208,686) (1,055,985)
Issuance of related party note     (55,000)
Net cash provided by financing activities 3,573,424 4,307,869 8,230,015 40,785
Effect of foreign exchange on cash (8,341) (19,573) (1,888)
Change in cash and cash equivalents during the period (300,390) (865,925) (589,123) (9,218,097)
Cash and cash equivalents, beginning of period 1,494,573 2,083,696 2,083,696 11,301,793
Cash and cash equivalents, end of period 1,194,183 1,217,771 1,494,573 2,083,696
Cash and cash equivalents consists of:        
Demand deposits 1,018,862 1,217,771    
Cash     1,404,160 2,083,696
Restricted cash 175,321 90,413
Total cash and cash equivalents 1,194,183 1,217,771 1,494,573 2,083,696
Supplemental Disclosure        
Cash paid for interest 37,754 26,187 59,777 16,000
Supplemental non-cash disclosures        
Reallocation of fair value of share options upon exercise 126,382 676,632 1,424,519 206,382
Reclassification of derivative liability for warrants priced with USD per change in functional currency     351,969
Reclassification of derivative liability of warrants priced with CAD per change in functional currency     4,541,545
Reclassification of derivative liability for warrants re-priced from CAD to USD exercise price 3,942,575 4,025,102
Common shares issued for share issuance costs 928,874 618,004 618,004
Warrants issued for share issuance costs 582,245 73,018 $ 402,166
Common shares issued for services $ 2,273,949